Finally, to assess if MEK1 is available in tumor tissue, we used the cohort of CRC patients from the initial discovery of MACC1 [4] for MEK1 expression analysis as well as samples from normal mucosa. Here, MAP2K1 is linked to colorectal carcinoma.